1	The	the	_	_	_	_	_	_	_
2	normal	normal	_	_	_	_	_	_	_
3	cell	cell	_	_	_	_	_	_	_
4	cycle	cycle	_	_	_	_	_	_	_
5	activation	activation	_	_	_	_	_	_	_
6	program	program	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	exploited	exploit	_	_	_	_	_	_	_
9	during	during	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	infection	infection	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	quiescent	quiescent	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	lymphocytes	lymphocyte	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
18	virus	virus	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	B	B	_	_	_	_	_	_	_
2	lymphocytes	lymphocyte	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	peripheral	peripheral	_	_	_	_	_	_	_
6	circulation	circulation	_	_	_	_	_	_	_
7	are	be	_	_	_	_	_	_	_
8	maintained	maintain	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	non-proliferative	non-proliferative	_	_	_	_	_	_	_
12	state	state	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	Antigen	antigen	_	_	_	_	_	_	_
2	recognition	recognition	_	_	_	_	_	_	_
3	stimulates	stimulate	_	_	_	_	_	_	_
4	limited	limited	_	_	_	_	_	_	_
5	proliferation	proliferation	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	whereas	whereas	_	_	_	_	_	_	_
8	infection	infection	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
11	virus	virus	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	EBV	EBV	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	results	result	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	continual	continual	_	_	_	_	_	_	_
18	proliferation	proliferation	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	outgrowth	outgrowth	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	immortal	immortal	_	_	_	_	_	_	_
24	cell	cell	_	_	_	_	_	_	_
25	lines	line	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Because	because	_	_	_	_	_	_	_
2	it	it	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	not	not	_	_	_	_	_	_	_
5	clear	clear	_	_	_	_	_	_	_
6	at	at	_	_	_	_	_	_	_
7	which	which	_	_	_	_	_	_	_
8	point	point	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	cell	cell	_	_	_	_	_	_	_
11	cycle	cycle	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	peripheral	peripheral	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	lymphocytes	lymphocyte	_	_	_	_	_	_	_
16	are	be	_	_	_	_	_	_	_
17	arrested	arrest	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	we	we	_	_	_	_	_	_	_
20	characterized	characterize	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	expression	expression	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	several	several	_	_	_	_	_	_	_
25	cell	cell	_	_	_	_	_	_	_
26	cycle-associated	cycle-associated	_	_	_	_	_	_	_
27	genes	gene	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	quiescent	quiescent	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	stimulated	stimulate	_	_	_	_	_	_	_
32	cells	cell	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	show	show	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	four	four	_	_	_	_	_	_	_
8	cell	cell	_	_	_	_	_	_	_
9	genes	gene	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	cdc-2	cdc-2	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	cyclin	cyclin	_	_	_	_	_	_	_
14	E	e	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	CD23	CD23	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	cyclin	cyclin	_	_	_	_	_	_	_
20	D2	d2	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	are	be	_	_	_	_	_	_	_
23	up-regulated	up-regulate	_	_	_	_	_	_	_
24	approximately	approximately	_	_	_	_	_	_	_
25	100-fold	100-fold	_	_	_	_	_	_	_
26	as	as	_	_	_	_	_	_	_
27	a	a	_	_	_	_	_	_	_
28	result	result	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	EBV-mediated	ebv-mediated	_	_	_	_	_	_	_
31	immortalization	immortalization	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Because	because	_	_	_	_	_	_	_
2	these	these	_	_	_	_	_	_	_
3	genes	gene	_	_	_	_	_	_	_
4	play	play	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	positive	positive	_	_	_	_	_	_	_
7	role	role	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	cell	cell	_	_	_	_	_	_	_
10	proliferation	proliferation	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	we	we	_	_	_	_	_	_	_
13	suggest	suggest	_	_	_	_	_	_	_
14	that	that	_	_	_	_	_	_	_
15	this	this	_	_	_	_	_	_	_
16	regulatory	regulatory	_	_	_	_	_	_	_
17	switch	switch	_	_	_	_	_	_	_
18	contributes	contribute	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	controlling	control	_	_	_	_	_	_	_
21	entry	entry	_	_	_	_	_	_	_
22	into	into	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	cell	cell	_	_	_	_	_	_	_
25	cycle	cycle	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Transient	transient	_	_	_	_	_	_	_
2	stimulation	stimulation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	quiescent	quiescent	_	_	_	_	_	_	_
5	B	B	_	_	_	_	_	_	_
6	lymphocytes	lymphocyte	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	either	either	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	cocktail	cocktail	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	anti-CD40	anti-cd40	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	anti-IgM	anti-IgM	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	IL4	il4	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	or	or	_	_	_	_	_	_	_
20	EBV	EBV	_	_	_	_	_	_	_
21	results	result	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	rapid	rapid	_	_	_	_	_	_	_
25	expression	expression	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	same	same	_	_	_	_	_	_	_
29	four	four	_	_	_	_	_	_	_
30	genes	gene	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	suggesting	suggest	_	_	_	_	_	_	_
33	that	that	_	_	_	_	_	_	_
34	,	,	_	_	_	_	_	_	_
35	after	after	_	_	_	_	_	_	_
36	infection	infection	_	_	_	_	_	_	_
37	,	,	_	_	_	_	_	_	_
38	EBV	EBV	_	_	_	_	_	_	_
39	exploits	exploit	_	_	_	_	_	_	_
40	the	the	_	_	_	_	_	_	_
41	normal	normal	_	_	_	_	_	_	_
42	program	program	_	_	_	_	_	_	_
43	of	of	_	_	_	_	_	_	_
44	B-lymphocyte	B-lymphocyte	_	_	_	_	_	_	_
45	cell	cell	_	_	_	_	_	_	_
46	cycle	cycle	_	_	_	_	_	_	_
47	activation	activation	_	_	_	_	_	_	_
48	.	.	_	_	_	_	_	_	_

